
Labs in Court Weekly Roundup
False and fraudulent claims and billing were the theme in key enforcement actions relating to the health care industry announced last week.
False and fraudulent claims and billing were the theme in key enforcement actions relating to the health care industry announced last week.
In this month’s key cases, Myriad Genetics shells out, Illumina wins a decisive victory, a whistleblower suit is tossed, and false billing of UDTs costs a lab at least $11.6 million.
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
All of last week’s key cases announced by the DOJ involving the health care industry related to companies settling false claims-related allegations.
...